Lung stem-cell-derived EV-based decoys, retaining maternal cellular features, demonstrate improved therapeutic efficiency over those derived from human embryonic kidney (HEK) cells 55
The Benefits Far Outweigh the Risks For most patients, the benefits of GLP-1 agonists far outweigh the potential risks
when discontinued, these mechanisms stop and eating behavior often reverts
"It was particularly interesting to learn what lasting impacts a GLP-1 medication may have on consumers they continue to try to maintain those healthy eating habits even as the 'food noise' returns." "As a result of the study, we have identified key implications for brands and retailers regarding product prioritizations and how we can best convey product benefits to support weight loss journeys, both during and post GLP-1 therapy," said Jami McDermid, president, CROSSMARK Sales Agency, a division of Acosta Group
Evaluation of adverse events in self-reported sulfa-allergic patients using topical carbonic anhydrase inhibitors